Weiser Michael

Iovance Biotherapeutics, Inc. · Director

Weiser Michael is listed in filings as Director at Iovance Biotherapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 17, 2025, including 2 public disclosures. Recent filings connect the profile to Iovance Biotherapeutics, Inc. (IOVA). The current snapshot covers public activity from Jun 13, 2024 to Jun 17, 2025. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

Latest Trades

CompanyValueActionPriceCurrent Price
No direct insider buys or sells are available yet.